A Review of the Efficacy of FDA-Approved B. anthracis Anti-Toxin Agents When Combined with Antibiotic or Hemodynamic Support in Infection- or Toxin-Challenged Preclinical Models

Anti-toxin agents for severe B. anthracis infection will only be effective if they add to the benefit of the two mainstays of septic shock management, antibiotic therapy and titrated hemodynamic support. Both of these standard therapies could negate benefits related to anti-toxin treatment. At prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Couse, Zoe, Cui, Xizhong, Li, Yan, Moayeri, Mahtab, Leppla, Stephen, Eichacker, Peter Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828353/
https://www.ncbi.nlm.nih.gov/pubmed/33450877
http://dx.doi.org/10.3390/toxins13010053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828353/
https://www.ncbi.nlm.nih.gov/pubmed/33450877
http://dx.doi.org/10.3390/toxins13010053

Ejemplares similares